FDA

Last week, President Obama signed into law the Food and Drug Administration Safety and Innovation Act (FDASIA). Among the numerous…

After three years of work the Food and Drug Administration (FDA) released its final Risk Evaluation and Mitigation Strategies…

The Food and Drug Administration (FDA) released a “Blueprint for Prescriber Continuing Education Program” regarding the use of…

As we noted last week, a group of bipartisan Senators including Senators Amy Klobuchar (D-MN), Richard Burr (R-NC), and Michael…

Last June, the United States Supreme Court, in a landmark decision, invalidated a Vermont law, which tried to restrict commercial…

This week, the Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced new actions for the…

Patients dying of cancer or suffering from diabetes often do not have the means to advocate for more research or treatments to…

This week, the United States Department of Justice (DOJ) announced that it has reached a resolution regarding the previously…

Progress in medicine is essential for discovering new ways to make people healthier, experience less pain, and to live longer. The…

 Non product specific, non accredited education programs focusing on disease state awareness are one of the most recent additions…